Correlation Between Bristol Myers and Johnson Johnson

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Bristol Myers and Johnson Johnson at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bristol Myers and Johnson Johnson into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bristol Myers Squibb and Johnson Johnson, you can compare the effects of market volatilities on Bristol Myers and Johnson Johnson and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bristol Myers with a short position of Johnson Johnson. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bristol Myers and Johnson Johnson.

Diversification Opportunities for Bristol Myers and Johnson Johnson

0.21
  Correlation Coefficient

Modest diversification

The 3 months correlation between Bristol and Johnson is 0.21. Overlapping area represents the amount of risk that can be diversified away by holding Bristol-Myers Squibb and Johnson Johnson in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Johnson Johnson and Bristol Myers is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bristol Myers Squibb are associated (or correlated) with Johnson Johnson. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Johnson Johnson has no effect on the direction of Bristol Myers i.e., Bristol Myers and Johnson Johnson go up and down completely randomly.

Pair Corralation between Bristol Myers and Johnson Johnson

Considering the 90-day investment horizon Bristol Myers Squibb is expected to generate 1.74 times more return on investment than Johnson Johnson. However, Bristol Myers is 1.74 times more volatile than Johnson Johnson. It trades about 0.24 of its potential returns per unit of risk. Johnson Johnson is currently generating about -0.13 per unit of risk. If you would invest  5,092  in Bristol Myers Squibb on December 30, 2023 and sell it today you would earn a total of  331.00  from holding Bristol Myers Squibb or generate 6.5% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Bristol-Myers Squibb  vs.  Johnson Johnson

 Performance 
       Timeline  
Bristol-Myers Squibb 

Risk-Adjusted Performance

4 of 100

 
Low
 
High
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Bristol Myers Squibb are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of fairly strong primary indicators, Bristol Myers is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
Johnson Johnson 

Risk-Adjusted Performance

0 of 100

 
Low
 
High
Weak
Over the last 90 days Johnson Johnson has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively steady basic indicators, Johnson Johnson is not utilizing all of its potentials. The current stock price chaos, may contribute to medium-term losses for the stakeholders.

Bristol Myers and Johnson Johnson Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Bristol Myers and Johnson Johnson

The main advantage of trading using opposite Bristol Myers and Johnson Johnson positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bristol Myers position performs unexpectedly, Johnson Johnson can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Johnson Johnson will offset losses from the drop in Johnson Johnson's long position.
The idea behind Bristol Myers Squibb and Johnson Johnson pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.

Other Complementary Tools

Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Equity Valuation
Check real value of public entities based on technical and fundamental data
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance